Search results
ASH is the world’s largest professional society of clinicians and scientists who are dedicated to conquering blood diseases. Learn about ASH research, education, publications, advocacy, and membership programs.
- Log in or create an account
The American Society of Hematology (ASH) is the world’s...
- Research
A joint effort of the American Society of Hematology (ASH)...
- Education
Conversations in Hematology Education is a brand-new podcast...
- Advocacy
ASH is the leader in representing the interests of...
- Careers
ASH provides support to hematologists in all stages of their...
- Program and Schedule
Schedule and Program for the 2023 ASH Meeting on Hematologic...
- Newsroom
ASH, the world's largest professional society concerned with...
- ASH Membership
Join a diverse community of more than 18,000 hematologists...
- Log in or create an account
15 de nov. de 2022 · 6 Department of Internal Medicine, Division of Hematology, College of Medicine, The Ohio State University, Columbus, OH 15 The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Division of Hematology, Columbus, OH
15 de nov. de 2022 · Conclusions: In this cohort study there was a response to treatment at 6 weeks in 57% of patients with AIHA and 92% with ITP. For both AIHA and ITP none of the initial treatment types or patient characteristics showed significant differences in likelihood of response.
2 de nov. de 2023 · The Genomic and Transcriptomic Landscape of Myeloid Sarcoma and Associated Acute Myeloid Leukemia | Blood | American Society of Hematology. 617.Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis | November 2, 2023.
2 de nov. de 2023 · Genomic Profiles and Associated Survival Prognosticators in Black Patients with Acute Myeloid Leukemia | Blood | American Society of Hematology. 617.Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis | November 2, 2023.
Plenary Scientific Session. Program: General Sessions. Sunday, December 10, 2023: 2:00 PM-4:00 PM. Hall A (San Diego Convention Center) Co-chairs: Robert A. Brodsky, MD, Johns Hopkins University and Mohandas Narla, DSc, New York Blood Center Enterprises. Disclosures: